Literature DB >> 23575531

[Tumor suppressor role of chromatin-remodeling factor ARID1A].

Xiao-Qiang Guo1, Qiao-Xia Zhang, Wei-Ren Huang, Xiang-Lin Duan, Zhi-Ming Cai.   

Abstract

The mammalian SWI/SNF complex is one of ATP-dependent chromatin-remodeling complexes, which plays important roles in cell proliferation, differentiation, development and tumor suppression. ARID1A (AT-rich interactive domain-containing protein 1A) is a large subunit of SWI/SNF complex, and also an ARID family member with non- sequence-specific DNA binding activity. ARID1A is a tumor suppressor gene which is frequently mutated in many cancers, such as ovarian, bladder and gastric cancers. ARID1A can suppress cell proliferation through the up-regulation of p21 and the down-regulation of E2F-responsive genes. These findings on ARID1A and its role of tumor suppression contribute to understanding the mechanism of cancer development and developing new therapy for cancer.It is introduced in the review that ARID1A basic characteristic, related to cancer development, and biological role for full understanding of ARID1A.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23575531     DOI: 10.3724/sp.j.1005.2013.00255

Source DB:  PubMed          Journal:  Yi Chuan        ISSN: 0253-9772


  3 in total

Review 1.  Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy.

Authors:  Renumathy Dhanasekaran; Jean-Charles Nault; Lewis R Roberts; Jessica Zucman-Rossi
Journal:  Gastroenterology       Date:  2018-11-04       Impact factor: 22.682

2.  Altered ARID1A expression in colorectal cancer.

Authors:  Mehran Erfani; Seyed Vahid Hosseini; Maral Mokhtari; Mozhdeh Zamani; Kamran Tahmasebi; Mahvash Alizadeh Naini; Alireza Taghavi; John M Carethers; Minoru Koi; Hassan Brim; Pooneh Mokarram; Hassan Ashktorab
Journal:  BMC Cancer       Date:  2020-04-25       Impact factor: 4.430

3.  AT-rich interactive domain1A determines sensitivity to oxaliplatin in gastric cancer cells.

Authors:  Qing Liu; Qing-Qing Weng; Song-Fei Shen; Tao Jiang; Zhang-Chi Pan; Meng-Xin Lin; Yan-Qin Lan; Yao Wang; Qiang Chen; Chun-Mei Shi
Journal:  Transl Cancer Res       Date:  2020-12       Impact factor: 1.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.